Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 18, 2026
Gena Wang's Stock Ratings
Barclays Analyst
Gena Wang is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
-1.70%
Smart Score
Overall Average Return Percentile
32nd
Number of Ratings
100
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/15/2026 | RGNX | Buy Now | Regenxbio | $7.15 | 67.83% | $37 → $12 | Maintains | Overweight | Get Alert | |
| 04/06/2026 | CYTK | Buy Now | Cytokinetics | $63.11 | 50.53% | $87 → $95 | Maintains | Overweight | Get Alert | |
| 02/04/2026 | LEGN | Buy Now | Legend Biotech | $18.54 | 331.5% | $90 → $80 | Maintains | Overweight | Get Alert | |
| 01/28/2026 | CYTK | Buy Now | Cytokinetics | $63.11 | 37.85% | → $87 | Assumes | → Overweight | Get Alert | |
| 12/22/2025 | CYTK | Buy Now | Cytokinetics | $63.11 | 37.85% | $82 → $87 | Maintains | Overweight | Get Alert | |
| 11/24/2025 | RARE | Buy Now | Ultragenyx Pharmaceutical | $15.07 | 231.79% | $81 → $50 | Maintains | Overweight | Get Alert | |
| 11/13/2025 | LEGN | Buy Now | Legend Biotech | $18.54 | 385.44% | $94 → $90 | Maintains | Overweight | Get Alert | |
| 11/11/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $12.29 | 168.51% | $38 → $33 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | MRNA | Buy Now | Moderna | $227.50 | -89.01% | $31 → $25 | Maintains | Equal-Weight | Get Alert | |
| 11/07/2025 | NTLA | Buy Now | Intellia Therapeutics | $11.42 | 22.59% | $24 → $14 | Maintains | Overweight | Get Alert | |
| 11/07/2025 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 1251.35% | $5 → $1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 11/06/2025 | PTCT | Buy Now | PTC Therapeutics | $61.53 | 10.52% | $46 → $68 | Maintains | Equal-Weight | Get Alert | |
| 11/05/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 13.06% | $22 → $20 | Maintains | Equal-Weight | Get Alert | |
| 11/04/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -19.16% | $408 → $414 | Maintains | Equal-Weight | Get Alert | |
| 11/04/2025 | SLDB | Buy Now | Solid Biosciences | $5.92 | 52.03% | $10 → $9 | Maintains | Overweight | Get Alert | |
| 11/04/2025 | BCRX | Buy Now | BioCryst Pharma | $8.08 | 11.39% | $11 → $9 | Maintains | Equal-Weight | Get Alert | |
| 10/31/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | 125.78% | $460 → $527 | Maintains | Overweight | Get Alert | |
| 10/30/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $44.60 | 113% | $80 → $95 | Maintains | Overweight | Get Alert | |
| 10/28/2025 | BMRN | Buy Now | BioMarin Pharmaceutical | $54.60 | 46.52% | $86 → $80 | Maintains | Overweight | Get Alert | |
| 10/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $11.42 | 110.16% | $26 → $24 | Maintains | Overweight | Get Alert | |
| 10/17/2025 | CLLS | Buy Now | Cellectis | $1.05 | 661.9% | $4 → $8 | Maintains | Overweight | Get Alert | |
| 10/06/2025 | CYTK | Buy Now | Cytokinetics | $63.11 | 29.93% | $71 → $82 | Maintains | Overweight | Get Alert | |
| 09/25/2025 | KOD | Buy Now | Kodiak Sciences | $91.32 | -81.38% | $7 → $17 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 09/23/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $44.60 | 79.37% | $78 → $80 | Maintains | Overweight | Get Alert | |
| 09/03/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $44.60 | 74.89% | $58 → $78 | Maintains | Overweight | Get Alert | |
| 09/03/2025 | CYTK | Buy Now | Cytokinetics | $63.11 | 12.5% | $53 → $71 | Maintains | Overweight | Get Alert | |
| 08/22/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $44.60 | 30.04% | $57 → $58 | Maintains | Overweight | Get Alert | |
| 08/14/2025 | KOD | Buy Now | Kodiak Sciences | $91.32 | -92.33% | $4 → $7 | Maintains | Underweight | Get Alert | |
| 08/08/2025 | RNA | Buy Now | Avidity Biosciences | $7.61 | 714.72% | $59 → $62 | Maintains | Overweight | Get Alert | |
| 08/08/2025 | RGNX | Buy Now | Regenxbio | $7.15 | 417.48% | $50 → $37 | Maintains | Overweight | Get Alert | |
| 08/06/2025 | CRSP | Buy Now | CRISPR Therapeutics | $49.96 | 12.09% | $42 → $56 | Maintains | Equal-Weight | Get Alert | |
| 08/06/2025 | BEAM | Buy Now | Beam Therapeutics | $24.03 | -12.61% | $25 → $21 | Maintains | Equal-Weight | Get Alert | |
| 08/04/2025 | MRNA | Buy Now | Moderna | $227.50 | -86.37% | $40 → $31 | Maintains | Equal-Weight | Get Alert | |
| 08/01/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | 97.08% | $329 → $460 | Maintains | Overweight | Get Alert | |
| 07/30/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 24.36% | $10 → $22 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 07/29/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 24.36% | $10 → $22 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 07/29/2025 | PTCT | Buy Now | PTC Therapeutics | $61.53 | -25.24% | $42 → $46 | Maintains | Equal-Weight | Get Alert | |
| 07/27/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | -43.47% | $18 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert | |
| 07/22/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 1.75% | $32 → $18 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 07/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 80.89% | $29 → $32 | Maintains | Overweight | Get Alert | |
| 07/01/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $44.60 | 27.8% | $51 → $57 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 06/17/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 63.93% | $89 → $29 | Maintains | Overweight | Get Alert | |
| 06/10/2025 | RNA | Buy Now | Avidity Biosciences | $7.61 | 675.3% | $57 → $59 | Maintains | Overweight | Get Alert | |
| 05/16/2025 | SLDB | Buy Now | Solid Biosciences | $5.92 | 68.92% | $15 → $10 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 6656.76% | $9 → $5 | Maintains | Overweight | Get Alert | |
| 05/13/2025 | CLLS | Buy Now | Cellectis | $1.05 | 280.95% | $5 → $4 | Maintains | Overweight | Get Alert | |
| 05/09/2025 | CRSP | Buy Now | CRISPR Therapeutics | $49.96 | -15.93% | $56 → $42 | Maintains | Equal-Weight | Get Alert | |
| 05/09/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $12.29 | 209.19% | $45 → $38 | Maintains | Overweight | Get Alert | |
| 05/08/2025 | PTCT | Buy Now | PTC Therapeutics | $61.53 | -31.74% | $56 → $42 | Maintains | Equal-Weight | Get Alert | |
| 05/08/2025 | CYTK | Buy Now | Cytokinetics | $63.11 | -16.02% | $55 → $53 | Maintains | Overweight | Get Alert | |
| 05/07/2025 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 403.11% | $209 → $89 | Maintains | Overweight | Get Alert | |
| 05/07/2025 | BCRX | Buy Now | BioCryst Pharma | $8.08 | 36.14% | $8 → $11 | Maintains | Equal-Weight | Get Alert | |
| 05/07/2025 | BEAM | Buy Now | Beam Therapeutics | $24.03 | 4.04% | $31 → $25 | Maintains | Equal-Weight | Get Alert | |
| 05/02/2025 | MRNA | Buy Now | Moderna | $227.50 | -82.42% | $45 → $40 | Maintains | Equal-Weight | Get Alert | |
| 04/24/2025 | CYTK | Buy Now | Cytokinetics | $63.11 | -12.85% | → $55 | Initiates | → Overweight | Get Alert | |
| 03/31/2025 | BLUE | Buy Now | bluebird bio | — | — | $40 → $8 | Maintains | Overweight | Get Alert | |
| 02/28/2025 | RNA | Buy Now | Avidity Biosciences | $7.61 | 649.01% | $63 → $57 | Maintains | Overweight | Get Alert | |
| 02/28/2025 | VIR | Buy Now | Vir Biotechnology | $10.28 | 201.56% | $26 → $31 | Maintains | Overweight | Get Alert | |
| 02/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $11.42 | 127.67% | $55 → $26 | Maintains | Overweight | Get Alert | |
| 02/18/2025 | MRNA | Buy Now | Moderna | $227.50 | -80.22% | $111 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/12/2025 | CRSP | Buy Now | CRISPR Therapeutics | $49.96 | 12.09% | $55 → $56 | Maintains | Equal-Weight | Get Alert | |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -8.81% | $435 → $467 | Maintains | Equal-Weight | Get Alert | |
| 01/31/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -15.06% | $418 → $435 | Maintains | Equal-Weight | Get Alert | |
| 12/31/2024 | BLUE | Buy Now | bluebird bio | — | — | $2 → $40 | Maintains | Overweight | Get Alert | |
| 12/20/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -18.38% | $509 → $418 | Maintains | Equal-Weight | Get Alert | |
| 12/13/2024 | EDIT | Buy Now | Editas Medicine | $2.41 | 24.48% | $5 → $3 | Maintains | Equal-Weight | Get Alert | |
| 12/03/2024 | PTCT | Buy Now | PTC Therapeutics | $61.53 | -8.99% | $45 → $56 | Maintains | Equal-Weight | Get Alert | |
| 11/15/2024 | KOD | Buy Now | Kodiak Sciences | $91.32 | -95.62% | $3 → $4 | Maintains | Underweight | Get Alert | |
| 11/15/2024 | BLUE | Buy Now | bluebird bio | — | — | $4 → $2 | Maintains | Overweight | Get Alert | |
| 11/14/2024 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 12062.16% | $3 → $9 | Maintains | Overweight | Get Alert | |
| 11/14/2024 | PTCT | Buy Now | PTC Therapeutics | $61.53 | -26.86% | $43 → $45 | Maintains | Equal-Weight | Get Alert | |
| 11/11/2024 | PTCT | Buy Now | PTC Therapeutics | $61.53 | -30.12% | $31 → $43 | Maintains | Equal-Weight | Get Alert | |
| 11/08/2024 | MRNA | Buy Now | Moderna | $227.50 | -51.21% | $125 → $111 | Maintains | Overweight | Get Alert | |
| 11/08/2024 | NTLA | Buy Now | Intellia Therapeutics | $11.42 | 381.61% | $76 → $55 | Maintains | Overweight | Get Alert | |
| 11/07/2024 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 1081.46% | $203 → $209 | Maintains | Overweight | Get Alert | |
| 11/06/2024 | CRSP | Buy Now | CRISPR Therapeutics | $49.96 | 10.09% | $59 → $55 | Maintains | Equal-Weight | Get Alert | |
| 11/05/2024 | EDIT | Buy Now | Editas Medicine | $2.41 | 107.47% | $7 → $5 | Maintains | Equal-Weight | Get Alert | |
| 11/05/2024 | CLLS | Buy Now | Cellectis | $1.05 | 376.19% | $7 → $5 | Maintains | Overweight | Get Alert | |
| 11/05/2024 | BCRX | Buy Now | BioCryst Pharma | $8.08 | -0.99% | $7 → $8 | Maintains | Equal-Weight | Get Alert | |
| 11/04/2024 | VIR | Buy Now | Vir Biotechnology | $10.28 | 152.92% | $28 → $26 | Maintains | Overweight | Get Alert | |
| 11/01/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | 40.95% | $295 → $329 | Maintains | Overweight | Get Alert | |
| 10/04/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 57.51% | $110 → $86 | Maintains | Overweight | Get Alert | |
| 09/16/2024 | MRNA | Buy Now | Moderna | $227.50 | -45.05% | $155 → $125 | Maintains | Overweight | Get Alert | |
| 08/28/2024 | RNA | Buy Now | Avidity Biosciences | $7.61 | 727.86% | → $63 | Initiates | → Overweight | Get Alert | |
| 08/15/2024 | BLUE | Buy Now | bluebird bio | — | — | $8 → $4 | Maintains | Overweight | Get Alert | |
| 08/14/2024 | SLDB | Buy Now | Solid Biosciences | $5.92 | 153.38% | $18 → $15 | Maintains | Overweight | Get Alert | |
| 08/09/2024 | PTCT | Buy Now | PTC Therapeutics | $61.53 | -49.62% | $25 → $31 | Maintains | Equal-Weight | Get Alert | |
| 08/08/2024 | EDIT | Buy Now | Editas Medicine | $2.41 | 190.46% | $9 → $7 | Maintains | Equal-Weight | Get Alert | |
| 08/08/2024 | SRPT | Buy Now | Sarepta Therapeutics | $17.69 | 1047.54% | $226 → $203 | Maintains | Overweight | Get Alert | |
| 08/07/2024 | BEAM | Buy Now | Beam Therapeutics | $24.03 | 29.01% | $33 → $31 | Maintains | Equal-Weight | Get Alert | |
| 08/06/2024 | CRSP | Buy Now | CRISPR Therapeutics | $49.96 | 18.09% | $67 → $59 | Maintains | Equal-Weight | Get Alert | |
| 08/06/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 101.46% | $111 → $110 | Maintains | Overweight | Get Alert | |
| 08/06/2024 | BCRX | Buy Now | BioCryst Pharma | $8.08 | -13.37% | $6 → $7 | Maintains | Equal-Weight | Get Alert | |
| 08/05/2024 | RGNX | Buy Now | Regenxbio | $7.15 | 599.3% | $55 → $50 | Maintains | Overweight | Get Alert | |
| 08/05/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $15.07 | 437.49% | $83 → $81 | Maintains | Overweight | Get Alert | |
| 08/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -0.61% | $472 → $509 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/02/2024 | MRNA | Buy Now | Moderna | $227.50 | -31.87% | $168 → $155 | Maintains | Overweight | Get Alert | |
| 08/02/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $44.60 | 14.35% | $45 → $51 | Maintains | Equal-Weight | Get Alert | |
| 08/02/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | 26.39% | $291 → $295 | Maintains | Overweight | Get Alert | |
| 08/02/2024 | VIR | Buy Now | Vir Biotechnology | $10.28 | 172.37% | $27 → $28 | Maintains | Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved